300289 Beijing Leadman Biochemistry
- 5.60
- +0.06+1.08%
Beijing Leadman Biochemistry News
Leadman: Supplemental Announcement on the Acquisition of Minority Shareholders\' Shares and Related Transactions of Holding Subsidiaries Desai Systems and Desai Products
Leadman: Announcement on the acquisition of minority shareholder shares and related transactions of the holding subsidiary Desai Systems and Desai Products
Leadman: 2021 Annual Equity Distribution Implementation Notice
Leadman: Announcement on 2021 Profit Distribution Plan
Leadman: Response Report to the Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets (Second Revised Draft)
Leadman: Zhongqin Wanxin Certified Public Accountants (Special General Partnership)'s response to the “Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets”
Leadman: 1-1 Prospectus (Application Draft)
Leadman: Zhongqin Wanxin Certified Public Accountants (Special General Partnership)'s response to the “Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets”
Leadman: Response Report to the Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets (Revised Draft)
Leadman: 1-1 Prospectus (Application Draft)
Leadman: 1-1 Prospectus (Application Draft)
Leadman: Response report to the audit inquiry letter on Beijing Leadman Biochemical Co., Ltd.'s application to issue shares to specific targets
Leadman: Zhongqin Wanxin Certified Public Accountants (Special General Partnership)'s response to the “Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets”
Leadman: 1-1 Prospectus (Application Draft)
Leadman: Audit inquiry letter on Beijing Leadman Biochemical Co., Ltd.'s application to issue shares to specific targets
Leadman: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
Leadman: 3-3 Listing Sponsorship Letter (Filing Draft)
Leadman: 1-1 Prospectus (Application Draft)
Leadman: 4-1 Legal Opinion (Report Draft)
Leadman: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)
No Data